enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Health Rounds: Next generation Lilly weight-loss drug shows ...

   www.aol.com/news/health-rounds-next-generation...

   Eli Lilly's experimental next generation weight-loss drug mimics three hormones instead of just one or two and continues to show promising clinical trial results for additional health benefits ...

3. Next-generation drug from Eli Lilly boosts weight loss to 24% ...

   www.aol.com/next-generation-drug-eli-lilly...

   An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen yet ...

4. An experimental drug drove people to lose 23% of their body ...

   www.aol.com/news/novo-nordisk-next-generation...

   Lilly’s Zepbound, approved in November 2023 as the Indiana-based drug giant’s answer to Novo Nordisk’s Wegovy, showed 21% average weight loss after 72 weeks for its highest dose in its Phase ...

5. Lilly weight loss drug prevents diabetes, company says - AOL

   www.aol.com/news/lilly-weight-loss-drug-prevents...

   Drug giant Eli Lilly says its weight-loss drug tirzepatide helps people with obesity avoid getting diabetes, even months after stopping the medication. ... Other GLP-1 drugs, which include ...

6. Eli Lilly's weight-loss drug may prevent diabetes - AOL

   www.aol.com/eli-lillys-weight-loss-drug...

   The weight loss benefits of taking Eli Lilly's dual-agonist drug, (generically called tirzepatide) were profound. Patients on the highest dose of the drug lost, on average, more than 22% of their ...

7. Lilly says weight loss drug cuts heart failure risk by ... - AOL

   www.aol.com/news/lilly-says-weight-loss-drug...

   The drug led to 15.7% weight loss in the combined population of people with and without type 2 diabetes, compared with 2.2% for the placebo, Lilly said. For the non-diabetes patients, weight loss ...